A Study of DS-3939a in Participants With Solid Tumors

NCT07739966 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Locally Advanced Non-Small Cell Lung Cancer
Metastatic Non-Small Cell Lung Cancer

Interventions

DRUG: DS-3939a
DRUG: Pembrolizumab
DRUG: Carboplatin
DRUG: Pemetrexed
DRUG: DS-1103a

Sponsor

Daiichi Sankyo